To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

Clinical trial NCT04660435 · RECRUITING

Trial details

NCT number: NCT04660435
Sponsor: Fondazione Sandro Pitigliani
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Breast Cancer ER Positive Breast Cancer HER2-negative Breast Cancer

Start date: 2020-09-01
Primary completion: 2025-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.